Schwartz-jampel syndrome: report of five cases

We describe five patients with Schwartz-Jampel syndrome (SJS) examined at the outpatient service for neuromuscular disorders at our Institution from 1996 to 1999 with the objective of emphasizing the characteristic dysmorphic phenotype of SJS and its different clinical forms. Two cases presented SJS-type 1A, two had SJS-type 1B and one manifested SJS-type 2. Two boys with 3 and 13 years of age had generalized stiffness and the characteristic facial as well as osteoarticular changes from birth. Other two boys with 11 and 7 years had less marked dysmorphic changes at birth and manifested myotonia, as a limiting factor, during the second year of age. A girl with two months of age had severe myotonia from birth leading to feeding diffuculties. In all cases the diagnosis was based on dysmorphic features, and on electromyographic changes showing continuous electrical activity of muscle fibers. All were treated with carbamazepine, 20-30 mg/Kg since diagnosis. The four boys (all with normal intelligence) improved of myotonia in daily activities, markedly in three, and moderately in one. The girl did not improve and showed global development delay: by the last follow-up (at 20 months of age) she did not sit unsupported, and had mental retardation. Carbamazepine in SJS-type 1 improves general daily performance and psychological status of the patients.

Saved in:
Bibliographic Details
Main Authors: Reed,Umbertina Conti, Reimão,Rubens, Espíndola,Adriana Ávila, Kok,Fernando, Ferreira,Lúcio Gobbo, Resende,Maria Bernardete Dutra, Messias,Thelma Correia, Carvalho,Mary Souza, Diament,Aron, Scaff,Milberto, Marie,Suely Kazue Nagahashi
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 2002
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2002000500010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-282X2002000500010
record_format ojs
spelling oai:scielo:S0004-282X20020005000102002-09-24Schwartz-jampel syndrome: report of five casesReed,Umbertina ContiReimão,RubensEspíndola,Adriana ÁvilaKok,FernandoFerreira,Lúcio GobboResende,Maria Bernardete DutraMessias,Thelma CorreiaCarvalho,Mary SouzaDiament,AronScaff,MilbertoMarie,Suely Kazue Nagahashi Schwartz-Jampel syndrome myotonia carbamazepine We describe five patients with Schwartz-Jampel syndrome (SJS) examined at the outpatient service for neuromuscular disorders at our Institution from 1996 to 1999 with the objective of emphasizing the characteristic dysmorphic phenotype of SJS and its different clinical forms. Two cases presented SJS-type 1A, two had SJS-type 1B and one manifested SJS-type 2. Two boys with 3 and 13 years of age had generalized stiffness and the characteristic facial as well as osteoarticular changes from birth. Other two boys with 11 and 7 years had less marked dysmorphic changes at birth and manifested myotonia, as a limiting factor, during the second year of age. A girl with two months of age had severe myotonia from birth leading to feeding diffuculties. In all cases the diagnosis was based on dysmorphic features, and on electromyographic changes showing continuous electrical activity of muscle fibers. All were treated with carbamazepine, 20-30 mg/Kg since diagnosis. The four boys (all with normal intelligence) improved of myotonia in daily activities, markedly in three, and moderately in one. The girl did not improve and showed global development delay: by the last follow-up (at 20 months of age) she did not sit unsupported, and had mental retardation. Carbamazepine in SJS-type 1 improves general daily performance and psychological status of the patients.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.60 n.3B 20022002-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2002000500010en10.1590/S0004-282X2002000500010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Reed,Umbertina Conti
Reimão,Rubens
Espíndola,Adriana Ávila
Kok,Fernando
Ferreira,Lúcio Gobbo
Resende,Maria Bernardete Dutra
Messias,Thelma Correia
Carvalho,Mary Souza
Diament,Aron
Scaff,Milberto
Marie,Suely Kazue Nagahashi
spellingShingle Reed,Umbertina Conti
Reimão,Rubens
Espíndola,Adriana Ávila
Kok,Fernando
Ferreira,Lúcio Gobbo
Resende,Maria Bernardete Dutra
Messias,Thelma Correia
Carvalho,Mary Souza
Diament,Aron
Scaff,Milberto
Marie,Suely Kazue Nagahashi
Schwartz-jampel syndrome: report of five cases
author_facet Reed,Umbertina Conti
Reimão,Rubens
Espíndola,Adriana Ávila
Kok,Fernando
Ferreira,Lúcio Gobbo
Resende,Maria Bernardete Dutra
Messias,Thelma Correia
Carvalho,Mary Souza
Diament,Aron
Scaff,Milberto
Marie,Suely Kazue Nagahashi
author_sort Reed,Umbertina Conti
title Schwartz-jampel syndrome: report of five cases
title_short Schwartz-jampel syndrome: report of five cases
title_full Schwartz-jampel syndrome: report of five cases
title_fullStr Schwartz-jampel syndrome: report of five cases
title_full_unstemmed Schwartz-jampel syndrome: report of five cases
title_sort schwartz-jampel syndrome: report of five cases
description We describe five patients with Schwartz-Jampel syndrome (SJS) examined at the outpatient service for neuromuscular disorders at our Institution from 1996 to 1999 with the objective of emphasizing the characteristic dysmorphic phenotype of SJS and its different clinical forms. Two cases presented SJS-type 1A, two had SJS-type 1B and one manifested SJS-type 2. Two boys with 3 and 13 years of age had generalized stiffness and the characteristic facial as well as osteoarticular changes from birth. Other two boys with 11 and 7 years had less marked dysmorphic changes at birth and manifested myotonia, as a limiting factor, during the second year of age. A girl with two months of age had severe myotonia from birth leading to feeding diffuculties. In all cases the diagnosis was based on dysmorphic features, and on electromyographic changes showing continuous electrical activity of muscle fibers. All were treated with carbamazepine, 20-30 mg/Kg since diagnosis. The four boys (all with normal intelligence) improved of myotonia in daily activities, markedly in three, and moderately in one. The girl did not improve and showed global development delay: by the last follow-up (at 20 months of age) she did not sit unsupported, and had mental retardation. Carbamazepine in SJS-type 1 improves general daily performance and psychological status of the patients.
publisher Academia Brasileira de Neurologia - ABNEURO
publishDate 2002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2002000500010
work_keys_str_mv AT reedumbertinaconti schwartzjampelsyndromereportoffivecases
AT reimaorubens schwartzjampelsyndromereportoffivecases
AT espindolaadrianaavila schwartzjampelsyndromereportoffivecases
AT kokfernando schwartzjampelsyndromereportoffivecases
AT ferreiraluciogobbo schwartzjampelsyndromereportoffivecases
AT resendemariabernardetedutra schwartzjampelsyndromereportoffivecases
AT messiasthelmacorreia schwartzjampelsyndromereportoffivecases
AT carvalhomarysouza schwartzjampelsyndromereportoffivecases
AT diamentaron schwartzjampelsyndromereportoffivecases
AT scaffmilberto schwartzjampelsyndromereportoffivecases
AT mariesuelykazuenagahashi schwartzjampelsyndromereportoffivecases
_version_ 1756374215774175232